Back
PDS Biotechnology 10K Form
Sell
47
PDSB
PDS Biotechnology
Last Price:
3.28
Seasonality Move:
44.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-13 | 10Q | PDSB/PDS Biotechnology Quarterly |
| 2020-05-13 | 10Q | PDSB/PDS Biotechnology Quarterly |
| 2020-03-27 | 10K | PDSB/PDS Biotechnology Annual |
| 2019-11-07 | 10Q | PDSB/PDS Biotechnology Quarterly |
| 2019-08-01 | 10Q | PDSB/PDS Biotechnology Quarterly |
| 2019-05-14 | 10Q | PDSB/PDS Biotechnology Quarterly |
Receive PDSB News And Ratings
See the #1 stock for the next 7 days that we like better than PDSB
PDSB Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-8.46M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.79 |
| Price / Book: | 4.59 |
Profitability
| EPS (TTM): | -1.39000 |
|---|---|
| Net Income (TTM): | $-42.94M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
PDS Biotechnology Earnings Forecast
Key PDS Biotechnology Financial Ratios
- The Interest Expense is -9.79% of Operating Income.
- Per Share Earnings over the last 11 years have been positive in 6 years.
PDS Biotechnology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PDSB |
| CUSIP: | 70465T |
| Website: | pdsbiotech.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PDSB Technical Analysis vs Fundamental Analysis
Sell
47
PDS Biotechnology (PDSB)
is a Sell
Is PDS Biotechnology a Buy or a Sell?
-
PDS Biotechnology stock is rated a Sell
The current PDS Biotechnology [PDSB] share price is $3.27. The Score for PDSB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.